Rain Enhancement Technologies to Discuss Business Progress on Wednesday, August 12, 2026 Life Science Investing
Accuray to Report Fourth Quarter Fiscal 2026 Financial Results on August 19, 2026 Medical Device Investing
Exelixis Announces Second Quarter 2026 Financial Results and Provides Corporate Update Life Science Investing
KORU Medical Systems Announces Second Quarter 2026 Results and Updates Full Year 2026 Guidance Life Science Investing
Tenaya Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update Life Science Investing
A CEO With a Proven Track Record of Success in Growing and Scaling Biopharmaceutical Companies Just Appointed CEO at a Clinical-Stage Biotech, Months Before Its Pivotal Phase 3 Readout Medical Device Investing
PTC Strengthens ALM Portfolio with New AI and Configuration Management Capabilities for Enterprise Complexity Life Science Investing
Journey Medical Corporation to Announce Second Quarter 2026 Financial Results on August 12, 2026 Life Science Investing
Enveric Biosciences Reports New Preclinical Data Supporting the Non-Hallucinogenic Profile of Lead Candidate EB-003 Life Science Investing
